{
    "clinical_study": {
        "@rank": "85626", 
        "arm_group": {
            "arm_group_label": "Drug", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to extend the use of opicapone 25 or 50mg once per day by\n      subjects who participated in the BIA 9-1067-302 clinical trial according form 4a for\n      additional three years."
        }, 
        "brief_title": "Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial", 
        "condition": "Parkinson Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  clinical diagnosis with PD\n\n          -  subjects who are willing to participate in the trial.\n\n          -  subjects who participated in the BIA 9-1067-302 clinical trial.\n\n        Exclusion Criteria:\n\n          -  subjects who didn't take part at the BIA 9-1067-302 clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851850", 
            "org_study_id": "BIA-91067"
        }, 
        "intervention": {
            "arm_group_label": "Drug", 
            "description": "25mg or 50mg once per day", 
            "intervention_name": "Opicapone", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PD", 
            "Off periods", 
            "quality of life", 
            "dyskinesia", 
            "end-off-dose motor fluctuations"
        ], 
        "lastchanged_date": "May 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Petach Tiqva", 
                    "country": "Israel", 
                    "state": "Hamerkaz", 
                    "zip": "49100"
                }, 
                "name": "Rabin Medical Center"
            }, 
            "investigator": {
                "last_name": "Ruth Djaldetti, Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Continue Providing Care for Patient Who Participated in the BIA 9-1067-302 Clinical Trial", 
        "overall_contact": {
            "email": "ruthdjal@clalit.org.il", 
            "last_name": "Ruth Djaldetti, Professor", 
            "phone": "972-3-9378218/9"
        }, 
        "overall_contact_backup": {
            "email": "yar@clalit.org.il", 
            "last_name": "Yaniv Roditi, MSc", 
            "phone": "972-39236843"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "number of \"off\" periods during the day without worsening dyskinesia.", 
            "measure": "off periods", 
            "safety_issue": "No", 
            "time_frame": "6 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851850"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Rabin Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rabin Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}